Saira Khan Receives Prostate Cancer Funding
Saira Khan, PhD
, postdoctoral associate in the Division of Public Health Sciences at Washington University School of Medicine, has received a two-year, $170,000 Department of Defense Prostate Cancer Research Program Early Investigator Research Award. Her award, “Chemotherapeutic Potential of Metformin and Statins to Prevent Progression to Lethal Prostate Cancer,
” is a mentored grant with Bettina Drake, PhD, MPH
, associate professor of surgery, acting as primary mentor.
The primary objective of Dr. Khan’s study is to assess the chemotherapeutic potential of metformin and statins to prevent progression to lethal prostate cancer in a large, ethnically diverse cohort of veterans diagnosed with prostate cancer. The study will assess whether using metformin and statins late in the disease course (i.e., after diagnosis with metastatic prostate cancer or after biochemical recurrence) can improve survival outcomes in men with prostate cancer.
The T32 Transdisciplinary Cancer Prevention and Control Training Program in the Division of Public Health Sciences at Washington University School of Medicine provides scholars from a broad range of disciplines the opportunity to develop skills in cancer prevention and control research and experience with transdisciplinary approaches. The program is a unique asset to the school and region, as it prepares both PhD and MD researchers to be independent investigators in transdisciplinary research for cancer prevention and control.